Pancreatic Cancer Research

ResearcherKumamoto UniversityNo recent work listed

Hideo Baba

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3183-3115; OpenAlex author ID A5109472611. Sources: OpenAlex.

Their work

Papers
10 (first author 0, last author 6)
Trials
0
Grants
0
Labs led
1
Collaborators
42
Papers, trials and grants by year

2011: 1 paper · 2012: 1 paper · 2013: 1 paper · 2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: 3 papers · 2019: none · 2020: 1 paper · 2021: 2 papers

Papers 10

  1. Identification of laminin γ2 as a prognostic and predictive biomarker for determining response to gemcitabine-based therapy in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.ejca.2020.12.031↗
  2. Recent advances in artificial intelligence for pancreatic ductal adenocarcinoma. Last author DOI 10.3748/wjg.v27.i43.7480↗
  3. Successful Treatment for the Recurrent Liver Metastases of the Pancreatic Cancer by Multimodality Therapy. Last author DOI 10.1097/mpa.0000000000001622↗
  4. Resection for recurrent pancreatic cancer in the remnant pancreas after pancreatectomy is clinically promising: Results of a project study for pancreatic surge… Co-author DOI 10.1016/j.surg.2018.05.050↗
  5. Serum Marker Score Based on Prognostic Nutrition Index, Carcinoembryonic Antigen, and Carbohydrate Antigen 19-9 Is Associated With Recurrence for Patients Unde… Last author DOI 10.1097/mpa.0000000000001146↗
  6. MAPLE-PD trial (Mesenteric Approach vs. Conventional Approach for Pancreatic Cancer during Pancreaticoduodenectomy): study protocol for a multicenter randomize… Co-author DOI 10.1186/s13063-018-3002-z↗
  7. Pancreatic cancer in the remnant pancreas following primary pancreatic resection. Last author DOI 10.1007/s00595-013-0708-0↗
  8. Dynamic computed tomography of locally advanced pancreatic cancer: effect of low tube voltage and a hybrid iterative reconstruction algorithm on image quality. Co-author DOI 10.1097/rct.0b013e318296db2b↗
  9. An autopsy study to clarify characteristics of local recurrence after extended pancreatectomy with intraoperative radiation therapy in patients with pancreatic… Last author DOI 10.1007/s00423-012-0934-8↗
  10. Perioperative intra-arterial and systemic chemotherapy for pancreatic cancer. Last author DOI 10.1245/s10434-010-1384-6↗

Closest collaborators

The 25 strongest of 42 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kensuke Yamamura · 2 shared papers, 2020–2021 · strength 0.25
  2. Norio Uemura · 2 shared papers, 2020–2021 · strength 0.25
  3. Hiromitsu Hayashi · 2 shared papers, 2020–2021 · strength 0.25
  4. Masayuki Sho · 2 shared papers, 2018–2021 · strength 0.21
  5. Akira Chikamoto · 4 shared papers, 2012–2018 · strength 0.19
  6. Katsunori Imai · 2 shared papers, 2018–2020 · strength 0.18
  7. Takanobu Yamao · 2 shared papers, 2018–2020 · strength 0.18
  8. Suguru Yamada · 2 shared papers, 2018 · strength 0.15
  9. Hiroki Yamaue · 2 shared papers, 2018 · strength 0.15
  10. Tsutomu Fujii · 2 shared papers, 2018 · strength 0.15
  11. Tetsuji Takayama · 1 shared paper, 2021 · strength 0.15
  12. Satoshi Nishiwada · 1 shared paper, 2021 · strength 0.15
  13. Yasuyuki Okada · 1 shared paper, 2021 · strength 0.15
  14. Ajay Goel · 1 shared paper, 2021 · strength 0.15
  15. Zhao Liu · 1 shared paper, 2021 · strength 0.14
  16. Daisuke Hashimoto · 2 shared papers, 2014–2018 · strength 0.12
  17. Toru Takematsu · 1 shared paper, 2020 · strength 0.11
  18. Shoji Nakamori · 1 shared paper, 2018 · strength 0.09
  19. Masakazu Yamamoto · 1 shared paper, 2018 · strength 0.09
  20. Naoki Umezaki · 1 shared paper, 2018 · strength 0.08
  21. Hidetoshi Nitta · 1 shared paper, 2018 · strength 0.08
  22. Hirohisa Okabe · 1 shared paper, 2018 · strength 0.08
  23. Shigeki Nakagawa · 1 shared paper, 2018 · strength 0.08
  24. Masahiko Hirota · 2 shared papers, 2011–2014 · strength 0.07
  25. Yoshiaki Murakami · 1 shared paper, 2018 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.